Literature DB >> 959220

Circulating malignant cells and fibrinolysis during resection of colorectal cancer.

H White, J D Griffiths.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959220      PMCID: PMC1864324     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

Review 1.  The significance of the circulating cancer cell.

Authors:  A J Salsbury
Journal:  Cancer Treat Rev       Date:  1975-03       Impact factor: 12.111

2.  Factors affecting the development of metastatic cancer. Effect of alterations in clottin mechanism.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

3.  The time of metastasis and release of circulating tumor cells as determined in an experimental system.

Authors:  M D ROMSDAHL; E W CHU; R HUME; R R SMITH
Journal:  Cancer       Date:  1961 Jul-Aug       Impact factor: 6.860

4.  Metabolic fate of urokinase.

Authors:  H Tajima; J Ishiguro; R Nonaka; M Kurita; S Tanaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1974-04       Impact factor: 1.645

5.  Carcinoma of the colon and rectum: circulating malignant cells and five-year survival.

Authors:  J D Griffiths; J A McKinna; H D Rowbotham; P Tsolakidis; A J Salsbury
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

6.  Light and electron microscopic study of malignant melanoma cells, isolated from the peripheral blood.

Authors:  L Döbrössy; J Sugár; J Tóth
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1968

7.  Localisation of deep-venous thrombosis using technetium-99m-labelled urokinase.

Authors:  W T Millar; J F Smith
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

  7 in total
  6 in total

1.  Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.

Authors:  Hui Zhou; Jun-Ming Guo; Yan-Ru Lou; Xin-Jun Zhang; Fa-De Zhong; Zhen Jiang; Jia Cheng; Bing-Xiu Xiao
Journal:  J Mol Med (Berl)       Date:  2010-03-28       Impact factor: 4.599

2.  Large bowel cancer: the effect of perioperative blood transfusion on outcome.

Authors:  S Cheslyn-Curtis; L P Fielding; R Hittinger; J S Fry; R K Phillips
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

3.  Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer?

Authors:  R D Kingston; J W Fielding; M K Palmer
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

4.  The first international urokinase/warfarin trial in colorectal cancer.

Authors:  L Daly
Journal:  Clin Exp Metastasis       Date:  1991 Jan-Feb       Impact factor: 5.150

5.  Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.

Authors:  Junming Guo; Bingxiu Xiao; Xinjun Zhang; Zhijin Jin; Jian Chen; Lijun Qin; Xiongying Mao; Guangyu Shen; Hui Chen; Zhong Liu
Journal:  J Mol Med (Berl)       Date:  2004-10-13       Impact factor: 4.599

Review 6.  Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review.

Authors:  G Peach; C Kim; E Zacharakis; S Purkayastha; P Ziprin
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.